Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. MedisourceRx
WARNING LETTER
•MedisourceRx•June 10, 2025

MedisourceRx – FDA Warning Letter, Jun 10, 2025

Record Details

The FDA issued a Warning Letter to MedisourceRx following an inspection from May 27 to June 10, 2025, for significant violations related to its operations as an outsourcing facility. The company failed to meet conditions under section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA), primarily by not submitting a required adverse event report (Complaint Log # C25004) and possessing inadequate procedures for defining what constitutes a “serious” adverse event, as mandated by 21 CFR 310.305(b). These failures mean MedisourceRx"s compounded drug products do not qualify for regulatory exemptions typically afforded to outsourcing facilities.

Consequently, the drug products produced by MedisourceRx are deemed unapproved new drugs, misbranded due to lacking adequate directions for use, and in violation of specific adverse event reporting requirements. The company"s non-compliance subjects its drug products to new drug approval processes, comprehensive labeling requirements, and the Drug Supply Chain Security Act. Although some retroactive adverse event submissions were acknowledged, the FDA noted that current reporting procedures remain deficient.

MedisourceRx is required to take prompt corrective actions. The company must provide a written response within 15 working days, detailing specific steps taken to address these violations, measures to prevent their recurrence, and supporting documentation. Failure to adequately address these concerns may result in further legal enforcement actions by the FDA.

Company
MedisourceRx
Inspection date
June 10, 2025
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Daniel Hernandez
  • F. Gail Bormel (F.)
View Company Profile

ID · 1fbda26f-82db-460c-9e19-19e6a0a63187

Violation Codes10
FD&C Act 501(a)(2)(B)FD&C Act 505(a)FD&C Act 301(d)FD&C Act 301(a)FD&C Act 502(f)(1)FD&C Act 301(k)FD&C Act 501(a)(2)(A)FD&C Act 201(p)FD&C Act 50521 U.S.C. 351(a)(2)(A)

Full citation text and observation details available on the Dashboard.

Other documents for MedisourceRx
  • 483 - 2025-06-10June 10, 2025
  • 483 - 2020-10-22October 22, 2020
  • 483 - 2018-09-27September 27, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MedisourceRx
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.